Redox Biology · 2023 · 10 citations · 44 references
Life SciencesBiochemistryCell BiologyCellular MetabolismMetabolic PhysiologyMetabolismAdipose TissueBiological AgingCellular AgingCellular SenescenceOxidative StressReactive Oxygen SpeciesAdipose Stem CellsAdipose Tissue DysfunctionAdipose Tissue RemodelingCell SenescenceFibroblast Growth Factor 21 SignalingRedox HomeostasisSenescenceWhite Adipose Tissue Biology
The senescence of adipose stem cells (ASCs) impairs healthy adipose tissue remodeling, causing metabolic maladaptation to energy surplus. The intrinsic molecular pathways and potential therapy targets for ASC senescence are largely unclear. Here, we showed that visceral ASCs were prone to senescence that was caused by reactive oxygen species (ROS) overload, especially mitochondrial ROS. These senescent ASCs failed to sustain efficient glucose influx, pentose phosphate pathway (PPP) and redox homeostasis. We showed that CD90 silence restricted the glucose uptake by ASCs and thus disrupted their PPP and anti-oxidant system, resulting in ASC senescence. Notably, fibroblast growth factor 21 (FGF21) treatment significantly reduced the senescent phenotypes of ASCs by augmenting CD90 protein via glycosylation, which promoted glucose influx via the AKT-GLUT4 axis and therefore mitigated ROS overload. For diet-induced obese mice, chronic administration of low-dose FGF21 relieved their visceral white adipose tissue (VAT) dysfunction and systemic metabolic disorders. In particular, VAT homeostasis was restored in FGF21-treated obese mice, where ASC repertoire was markedly recovered, accompanied by CD90 elevation and anti-senescent phenotypes in these ASCs. Collectively, we reveal a molecular mechanism of ASC senescence by which CD90 downregulation interferes glucose influx into PPP and redox homeostasis. And we propose a FGF21-based strategy for healthy VAT remodeling, which targets CD90 glycosylation to correct ASC senescence and therefore combat obesity-related metabolic dysfunction.
44
FGF-21 as a novel metabolic regulator
Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester et al. · Journal of Clinical Investigation · 2005 · 2.1K citations · Full text
Tracking adipogenesis during white adipose tissue development, expansion and regeneration
Qiong Wang, Caroline Tao, Rana K. Gupta et al. · Nature Medicine · 2013 · 1.3K citations · Full text
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coşkun, Holly A. Bina, M. Schneider et al. · Endocrinology · 2008 · 1K citations
Hiroshi Kurosu, Mihwa Choi, Yasushi Ogawa et al. · Journal of Biological Chemistry · 2007 · 734 citations · Full text